Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal Update

14 Nov 2008 07:01

RNS Number : 1661I
Immunodiagnostic Systems Hldgs PLC
14 November 2008
 



Immunodiagnostic Systems Holdings plc

Immunodiagnostic Systems Holdings plc ("IDS") and Escalon Medical Corporation ("EMC"), the NASDAQ quoted healthcare Company, draw closer to conclusion of the acquisition of IDS' Biocode Hycel haematology division.

EMC and IDS today announce their collaboration on a plan to transfer IDS' Biocode Hycel haematology division to EMC or its subsidiary Drew Scientific Inc.

Discussions are at an advanced stage for the 100% divestment of this division by IDS.

The deal will be finalised assuming successful consultation with the competent employee representative bodies, as required by French Law, and after the subsequent finalisation and signing of the definitive agreement. This is expected to take place before the end of November at which point a further announcement will be made giving full details of the deal terms.

For further information:

Immunodiagnostic Systems Holdings plc  Tel: 0191 519 0660

Roger Duggan, Managing Director

Paul Hailes, Finance Director

Oriel Securities Limited (Nominated Adviser and Broker) Tel: 020 7710 7600

Andrew Edwards

Gareth Price

James Nevin

 

Parkgreen Communications Limited  Tel: 020 7933 8787

Paul McManus Mob: 07980 541 893

paul.mcmanus@parkgreenmedia.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISQZLBFVFBEFBV
Date   Source Headline
14th Apr 20057:01 amRNSResearch Agreement
21st Feb 200510:08 amRNSAcquisition
4th Feb 20054:30 pmRNSExercise of Options
18th Jan 20053:20 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.